Submitted by Ayanna Monteverdi on Wed, 12/04/2013 - 12:15 play pause stop mute unmute previous next 6-How are 23andMe results different from standard epidemiology risk assessments.mp3 Regulation Expert, Mya Thomae, Weighs in on FDA Letter to 23andMe" Part 6
